Abstract
The survival rates for patients living with cancer are increasing, due to recent advances in detection, prevention and treatment. It has been estimated that there were 28 million cancer survivors around the world in 2012. In the UK, for patients diagnosed in 2007, it is predicted that more than half of them will survive their cancer for 5 years or more. A large majority of cancer survivors report unmet supportive care needs and distressing symptoms and adverse long-term consequences related to their cancer. Cancer management could be optimized to better meet patients demand through technology, including mobile health (m-Health). m-Health is defined as the use of mobile communications and network technologies for health care. m-Health can help both patients and health-care professionals and play an important part in managing and delivering cancer care including managing side effects, supporting drug adherence, providing cancer information, planning and follow up and detecting and diagnosing cancer. Health authorities have already published guidelines regulating m-Health to insure patient safety and improve the accountability of its applications.
Similar content being viewed by others
References
American Cancer Society (2014) Cancer facts and statistics. American Cancer Society. http://www.cancer.org/research/cancerfactsstatistics/. Accessed 24 Mar 2014
Cancer Research UK (2014) Cancer survival statistics. Cancer Research UK. http://www.cancerresearchuk.org/cancer-info/cancerstats/survival/. Accessed 24 Mar 2014
Boyes AW, Girgis A, D’Este C, Zucca AC (2012) Prevalence and correlates of cancer survivors’ supportive care needs 6 months after diagnosis: a population-based cross-sectional study. BMC Cancer 12(1):150
Williamson S (2011) A report on the dispensing and supply of oral chemotherapy and systemic anticancer medicines in primary care. BOPA, RPS, NPA
Istepanian R, Laxminarayan S, Pattichis CS (2006) M-health: emerging mobile health systems. In: Istepanian R, Laxminarayan S, Pattichis CS (eds) 2006 XXX, 624 p 182 illus 0-387-26558-9 Berlin: Springer, 1
WHO (2010) mHealth new horizons for health through mobile technologies. Global observatory for eHealth series, vol 3. WHO, Geneva
ABI Research (2014) Q4 2013 Smartphone OS results: is Google losing control of the android ecosystem?
Sanou B (2013) The World in 2013: ICT facts and figures. International Telecommunications Union
Bender JL, Yue RYK, To MJ, Deacken L, Jadad AR (2013) A lot of action, but not in the right direction: systematic review and content analysis of smartphone applications for the prevention, detection, and management of cancer. J Med Internet Res 15(12)
Klasnja P, Pratt W (2012) Healthcare in the pocket: mapping the space of mobile-phone health interventions. J Biomed Inform 45(1):184–198
Wangberg SC, Årsand E, Andersson N (2006) Diabetes education via mobile text messaging. J Telemed Telecare 12(suppl 1):55–56
Chomutare T, Fernandez-Luque L, Årsand E, Hartvigsen G (2011) Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines. J Med Internet Res 13(3)
Krishna S, Boren SA, Balas EA (2009) Healthcare via cell phones: a systematic review. Telemed e-Health 15(3):231–240
Holtz B, Lauckner C (2012) Diabetes management via mobile phones: a systematic review. Telemed e-Health 18(3):175–184
Scherr D, Zweiker R, Kollmann A, Kastner P, Schreier G, Fruhwald F (2006) Mobile phone-based surveillance of cardiac patients at home. J Telemed Telecare 12(5):255–261
Rubel P, Fayn J, Nollo G, Assanelli D, Li B, Restier L, Adami S, Arod S, Atoui H, Ohlsson M (2005) Toward personal eHealth in cardiology. Results from the EPI-MEDICS telemedicine project. J Electrocardiol 38(4):100–106
Rosser BA, Eccleston C (2011) Smartphone applications for pain management. J Telemed Telecare 17(6):308–312
Pandey A, Hasan S, Dubey D, Sarangi S (2013) Smartphone apps as a source of cancer information: changing trends in health information-seeking behavior. J Cancer Educ 28(1):138–142
Obermayer JL, Riley WT, Asif O, Jean-Mary J (2004) College smoking-cessation using cell phone text messaging. J Am Coll Health 53(2):71–78
Haug S, Meyer C, Schorr G, Bauer S, John U (2009) Continuous individual support of smoking cessation using text messaging: a pilot experimental study. Nicotine Tob Res 11(8):915–923
Fairhurst K, Sheikh A (2008) Texting appointment reminders to repeated non-attenders in primary care: randomised controlled study. Qual Saf Health Care 17(5):373–376
Consolvo S, Klasnja P, McDonald DW, Avrahami D, Froehlich J, LeGrand L, Libby R, Mosher K, Landay JA (2008) Flowers or a robot army?: encouraging awareness & activity with personal, mobile displays. In: Proceedings of the 10th international conference on Ubiquitous computing. ACM, pp 54–63
Department of Health (2007) The cancer reform strategy. London
NHS Scotland (2007) Better health, better care: a discussion document. Scottish Executive, Edinburgh
Dranitsaris G, Maroun J, Shah A (2005) Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea. Can J Gastroenterol 19(2):83–87
Chen-Hardee S, Chrischilles EA, Voelker MD, Brooks JM, Scott S, Link BK, Delgado D (2006) Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin’s lymphoma (United States). Cancer Causes Control 17(5):647–654
Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106(10):2258–2266
Coolbrandt A, Van den Heede K, Vanhove E, De Bom A, Milisen K, Wildiers H (2011) Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: does timing matter? Eur J Oncol Nurs 15(2):130–136
Homsi J, Walsh D, Rivera N, Rybicki LA, Nelson KA, LeGrand SB, Davis M, Naughton M, Gvozdjan D, Pham H (2006) Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer 14(5):444–453
Kayyali R, Nabhani-Gebara S, Olszewska A, Adeniyi M (2012) Investigation of bowel and breast cancer patients’ perception of counselling and written information provided regarding the oral chemotherapy agent capecitabine. Int J Pharm Pract 20(S2):85
Nabhani-Gebara S, Kayyali R, Olszewska A (2013) Patient counselling—a dying art? Pharmacoepidemiol Drug Saf 22(6):684–685
Nabhani-Gebara S, Kayyali R, Olszewska A (2012) Patients’ perception of educational material surrounding their cancer treatment. Eur J Oncol Nurs 16(S1):S30
Weaver A, Young A, Rowntree J, Townsend N, Pearson S, Smith J, Gibson O, Cobern W, Larsen M, Tarassenko L (2007) Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol 18(11):1887–1892
Maguire R, Miller M, Sage M, Norrie J, McCann L, Taylor L, Kearney N (2005) Results of a UK based pilot study of a mobile phone based advanced symptom management system (ASyMS) in the remote monitoring of chemotherapy related toxicity. Clin Eff Nurs 9(3):202–210
Ghafoor S, Kayyali R, Nabhani-Gebara S, Sobnath D, Philip N (2013) Evaluating patients’ acceptability of alternative means of support for oral chemotherapy counselling and side effect management using a smartphone application. Int J Pharm Pract 21(2):27–28
Maguire R, McCann L, Miller M, Kearney N (2008) Nurse’s perceptions and experiences of using of a mobile-phone-based Advanced Symptom Management System (ASyMS©) to monitor and manage chemotherapy-related toxicity. Eur J Oncol Nurs 12(4):380–386
Kearney N, McCann L, Norrie J, Taylor L, Gray P, McGee-Lennon M, Sage M, Miller M, Maguire R (2009) Evaluation of a mobile phone-based, advanced symptom management system (ASyMS©) in the management of chemotherapy-related toxicity. Support Care Cancer 17(4):437–444
Gibson F, Aldiss S, Taylor RM, Maguire R, McCann L, Sage M, Kearney N (2010) Utilization of the Medical Research Council Evaluation Framework in the Development of Technology for Symptom Management: the ASyMS (c)-YG Study. Cancer Nurs 33(5):343–352
Baggott C (2013) Patient-reported outcomes collected via smartphone: adolescent cancer patients’ nausea trajectories. Eur J Oncol Nurs 17(6):895
Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94(9):652–661
Partridge AH, Ades T, Spicer P, Englander L, Wickerham DL (2007) Helping breast cancer patients adhere to oral adjuvant hormonal therapy regimens. Commun Oncol 4(12):725–731
Bedell CH (2003) A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents. Clin J Oncol Nurs 7:5–9
Thompson AMDJ, Fahey T, McCowan C (2007) Association of poor adherence to prescribed tamoxifen with risk of death from breast cancer. In: American Society of Clinical Oncology Breast Cancer Symposium USA
Ruddy K, Mayer E, Partridge A (2009) Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 59(1):56–66. doi:10.3322/caac.20004
Banna GL, Collova E, Gebbia V, Lipari H, Giuffrida P, Cavallaro S, Condorelli R, Buscarino C, Tralongo P, Ferrau F (2010) Anticancer oral therapy: emerging related issues. Cancer Treat Rev 36(8):595–605. doi:10.1016/j.ctrv.2010.04.005
Moore S (2007) Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs 30(2):112–122
Decker V, Spoelstra S, Miezo E, Bremer R, You M, Given C, Given B (2009) A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents. Cancer Nurs 32(6):E20–E29
Becker S, Kribben A, Meister S, Diamantidis CJ, Unger N, Mitchell A (2013) User profiles of a smartphone application to support drug adherence—experiences from the iNephro project. PLoS One 8(10):e78547
Smith TJ, Dow LA, Virago E, Khatcheressian J, Lyckholm LJ, Matsuyama R (2010) Giving honest information to patients with advanced cancer maintains hope. Oncology 24(6):521–525
Smith TJ, Dow LA, Virago EA, Khatcheressian J, Matsuyama R, Lyckholm LJ (2011) A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer. J Support Oncol 9(2):79
Matsuyama RK, Wilson-Genderson M, Kuhn L, Moghanaki D, Vachhani H, Paasche-Orlow M (2011) Education level, not health literacy, associated with information needs for patients with cancer. Patient Educ Couns 85(3):e229–e236
Dieng M, Trevena L, Turner RM, Wadolowski M, McCaffery K (2013) What Australian women want and when they want it: cervical screening testing preferences, decision‐making styles and information needs. Health Expect 16(2):177–188
Mistry A, Wilson S, Priestman T, Damery S, Haque M (2010) How do the information needs of cancer patients differ at different stages of the cancer journey? A cross-sectional survey. JRSM Short Rep 1(4):30
Halkett GK, Kristjanson LJ, Lobb E, Little J, Shaw T, Taylor M, Spry N (2012) Information needs and preferences of women as they proceed through radiotherapy for breast cancer. Patient Educ Couns 86(3):396–404
Güleser GN, Taşci S, Kaplan B (2012) The experience of symptoms and information needs of cancer patients undergoing radiotherapy. J Cancer Educ 27(1):46–53
Klasnja P, Hartzler A, Powell C, Phan G, Pratt W (2010) Health weaver mobile: designing a mobile tool for managing personal health information during cancer care. In: AMIA Annual Symposium Proceedings. American Medical Informatics Association, p 392
Payne KFB, Wharrad H, Watts K (2012) Smartphone and medical related App use among medical students and junior doctors in the United Kingdom (UK): a regional survey. BMC Med Inform Decis Mak 12(1):121
O’Neill S, Brady R (2012) Colorectal smartphone apps: opportunities and risks. Color Dis 14(9):e530–e534
Bibault J-E, Leroy T, Blanchard P, Biau J, Cervellera M, Diaz O, Faivre JC, Fumagalli I, Lescut N, Martin V (2014) Mobile technology and social media in the clinical practice of young radiation oncologists: results of a comprehensive nationwide cross-sectional study. Int J Radiat Oncol* Biol* Phys
Rozati H, Shah SP, Shah N (2014) Smartphone applications for the clinical oncologist in UK practice. J Cancer Educ 1–7
Brennan ME, Butow P, Marven M, Spillane AJ, Boyle FM (2011) Survivorship care after breast cancer treatment—experiences and preferences of Australian women. Breast 20(3):271–277
Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, Hantel A, Henry NL, Muss HB, Smith TJ (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(7):961–965
Hall SJ, Samuel LM, Murchie P (2011) Toward shared care for people with cancer: developing the model with patients and GPs. Fam Pract 28(5):554–564
Pascoe SW, Neal RD, Allgar VL, Selby PJ, Wright EP (2004) Psychosocial care for cancer patients in primary care? Recognition of opportunities for cancer care. Fam Pract 21(4):437–442
Rozmovits L, Rose P, Ziebland S (2004) In the absence of evidence, who chooses? A qualitative study of patients’ needs after treatment for colorectal cancer. J Health Serv Res Policy 9(3):159–164
Cox K, Wilson E, Heath L, Collier J, Jones L, Johnston I (2006) Preferences for follow-up after treatment for lung cancer: assessing the nurse-led option. Cancer Nurs 29(3):176–187
Donnelly P, Hiller L, Bathers S, Bowden S, Coleman R (2007) Questioning specialists’ attitudes to breast cancer follow-up in primary care. Ann Oncol
Okera M, Baker NA, Hayward A, Selva‐Nayagam S (2011) Oncology workforce issues: the challenge of the outpatient clinic. Intern Med J 41(6):499–503
Green J, Murchie P, Lee AJ (2013) Does patients’ place of residence affect the type of physician performing primary excision of cutaneous melanoma in northern Scotland? J Rural Health 29(s1):s35–s42
Dickinson R, Hall S, Sinclair JE, Bond C, Murchie P (2014) Using technology to deliver cancer follow-up: a systematic review. BMC Cancer 14(1):311
Matthew AG, Currie KL, Irvine J, Ritvo P, Santa Mina D, Jamnicky L, Nam R, Trachtenberg J (2007) Serial personal digital assistant data capture of health-related quality of life: a randomized controlled trial in a prostate cancer clinic. Health Qual Life Outcomes 5:38
Ott J, Ullrich A, Miller A (2009) The importance of early symptom recognition in the context of early detection and cancer survival. Eur J Cancer 45(16):2743–2748
Pontén J, Adami HO, Bergström R, Dillner J, Friberg LG, Gustafsson L, Miller AB, Parkin DM, Sparén P, Trichopoulos D (1995) Strategies for global control of cervical cancer. Int J Cancer 60(1):1–26
Teppo L, Dickman PW, Hakulinen T, Luostarinen T, Pukkala E, Sankila R, Söderman B (1999) Cancer patient survival—patterns, comparisons, trends: a population-based cancer registry study in Finland. Acta Oncol 38(3):283–294
Richards M, Westcombe A, Love S, Littlejohns P, Ramirez A (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353(9159):1119–1126
Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106(3):416–422
Vis AN, Roemeling S, Reedijk AM, Otto SJ, Schröder FH (2008) Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort. Eur Urol 53(1):91–98
Wang J-H, Changchien C-S, Hu T-H, Lee C-M, Kee K-M, Lin C-Y, Chen C-L, Chen T-Y, Huang Y-J, Lu S-N (2008) The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma—survival analysis of 3892 patients. Eur J Cancer 44(7):1000–1006
Horn L-C, Fischer U, Raptis G, Bilek K, Hentschel B (2007) Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 107(2):310–315
Wolf JA, Moreau JF, Akilov O, Patton T, English JC, Ho J, Ferris LK (2013) Diagnostic inaccuracy of smartphone applications for melanoma detection. JAMA Dermatol 149(4):422–426
Maier T, Kulichova D, Schotten K, Astrid R, Ruzicka T, Berking C, Udrea A (2014) Accuracy of a smartphone application using fractal image analysis of pigmented moles compared to clinical diagnosis and histological result. J Eur Acad Dermatol Venereol
Mobasheri MH, Johnston M, King D, Leff D, Thiruchelvam P, Darzi A (2014) Smartphone breast applications—what’s the evidence? Breast. doi:10.1016/j.breast.2014.07.006
Yuan C (2014) Mobile health in cancer care: a new solution or a potential risk? Cancer Nurs 37(2):83
Agu E, Pedersen P, Strong D, Tulu B, He Q, Wang L, Li Y (2013) The smartphone as a medical device: assessing enablers, benefits and challenges. In: Internet-of-Things Networking and Control (IoT-NC), 2013 I.E. International Workshop of. IEEE, pp 48–52
McCartney M (2013) How do we know whether medical apps work? BMJ: Br Med J 346
Buijink AWG, Visser BJ, Marshall L (2012) Medical apps for smartphones: lack of evidence undermines quality and safety. Evidence Based Medicine:ebmed-2012-100885
Medicines and Healthcare products Regulatory Agency (MHRA) (2014) Guidance on medical device stand-alone software (including apps). http://www.mhra.gov.uk/Howweregulate/Devices/Software/index.htm. Accessed 21 Aug 2014
NHS Choices (2014) Health apps library. http://apps.nhs.uk/. Accessed 21 Aug 2014
European Commission (2012) MEDDEV 2.1/6 -Guidelines on the qualification and classification of stand alone software used in healthcare within the regulatory framework of medical devices
US Food and Drug Administration (2013) Mobile medical applications: guidance for Industry and Food and Drug Administration Staff
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Odeh, B., Kayyali, R., Nabhani-Gebara, S. et al. Optimizing cancer care through mobile health. Support Care Cancer 23, 2183–2188 (2015). https://doi.org/10.1007/s00520-015-2627-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-015-2627-7